Nautilus Biotechnology, Inc.
NAUT • NASDAQ • Stock Fundamentals
Nautilus Biotechnology, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sujal Patel, with a market cap of $290.4M.
Market Cap$290.4M
Employees163.0
CEOSujal Patel
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsApr 28, 2026 · 1 month 17 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Nautilus Biotechnology, Inc. FAQ
Common questions about Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc. (NAUT) has a market capitalization of $290.4M and trades on NASDAQ.
Nautilus Biotechnology, Inc. has approximately 163 employees.